Systemic arthritis in children: A review of clinical presentation and treatment

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Gurion, R ^a   Lehman, T J A ^b   Moorthy, L N ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; AMYLOID A PROTEIN; CALCINEURIN INHIBITOR; CANAKINUMAB; CHROMOSOME PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; INTERLEUKIN 1BETA; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; PYRIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; RITUXIMAB; STEROID; THALIDOMIDE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMYLOIDOSIS; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; ANXIETY DISORDER; CATARACT; CHRONIC ARTHRITIS; CONSCIOUSNESS DISORDER; CREATININE BLOOD LEVEL; CUSHINGOID SYNDROME; DELAYED PUBERTY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; DRUG BINDING; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INTOXICATION; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DUODENITIS; ETHNICITY; FEVER; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL IRRITATION; GENETIC ASSOCIATION; GINGIVA HYPERPLASIA; GROWTH RETARDATION; HEPATOSPLENOMEGALY; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; HYPERTRICHOSIS; IMMUNE DEFICIENCY; INCIDENCE; JOINT STIFFNESS; JUVENILE RHEUMATOID ARTHRITIS; LYMPHADENOPATHY; LYMPHEDEMA; MACROPHAGE ACTIVATION SYNDROME; MEDICAL SOCIETY; MENTAL DISEASE; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOPATHY; OSTEOPOROSIS; PAIN; PATHOPHYSIOLOGY; PERICARDITIS; PERITONITIS; PLEURISY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PSEUDOPORPHYRIA; QUALITY OF LIFE; RASH; REMISSION; REVIEW; REYE SYNDROME; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL ISOLATION; STRIA; SYNOVIAL CYST; SYSTEMIC JUVENILE RHEUMATOID ARTHRITIS; UNSPECIFIED SIDE EFFECT; UVEITIS;

EID: 84858658227     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/271569     Document Type: Review

References (208)

1. Still G. F., On a form of chronic joint disease in children. Medico-Chirurgical Transactions 1897 80 47 60 2-s2.0-0025104219
2. Fink C., Proposal for the development of classification criteria for the idiopathic arthritides of childhood. Journal of Rheumatology 1995 22 8 1566 1569
3. Petty R. E., Southwood T. R., Manners P., Baum J., Glass D. N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A. M., Suarez-Almazor M. E., Woo P., International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. Journal of Rheumatology 2004 31 2 390 392 2-s2.0-10744230484 (Pubitemid 38160763)
4. Ramanan A. V., Grom A. A., Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology 2005 44 11 1350 1353 2-s2.0-27744435759 10.1093/rheumatology/keh710 (Pubitemid 41631856)
5. Behrens E. M., Beukelman T., Gallo L., Spangler J., Rosenkranz M., Arkachaisri T., Ayala R., Groh B., Finkel T. H., Cron R. Q., Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). Journal of Rheumatology 2008 35 2 343 348 2-s2.0-39549087921 (Pubitemid 351281158)
6. Feldman B. M., Birdi N., Boone J. E., Dent P. B., Duffy C. M., Ellsworth J. E., Lang B. A., Laxer R. M., Lewkonia R. M., Malleson P. N., Oen K. G., Paquin J. D., Rosenberg A. M., Schneider R., Silverman E. D., Seasonal onset of systemic-onset juvenile rheumatoid arthritis. The Journal of Pediatrics 1996 129 4 513 518 2-s2.0-0030365208 10.1016/S0022-3476(96)70115-4 (Pubitemid 27490787)
7. Modesto C., Antón J., Rodriguez B., Bou R., Arnal C., Ros J., Tena X., Rodrigo C., Rotés I., Hermosilla E., Barceló P., Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scandinavian Journal of Rheumatology 2010 39 6 472 479 2-s2.0-78649692274 10.3109/03009741003742722
8. Schneider R., Laxer R. M., Systemic onset juvenile rheumatoid arthritis. Bailliere's Clinical Rheumatology 1998 12 2 245 271 2-s2.0-0031726974 10.1016/S0950-3579(98)80018-6 (Pubitemid 28492906)
9. Wallace C. A., Levinson J. E., Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheumatic Disease Clinics of North America 1991 17 4 891 905 2-s2.0-0025757333
10. Pruunsild C., Uibo K., Liivamägi H., Tarraste S., Talvik T., Pelkonen P., Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scandinavian Journal of Rheumatology 2007 36 1 7 13 2-s2.0-34147218843 10.1080/03009740601089259 (Pubitemid 46578065)
11. Berntson L., Andersson Gäre B., Fasth A., Herlin T., Kristinsson J., Lahdenne P., Marhaug G., Nielsen S., Pelkonen P., Rygg M., Incidence of juvenile idiopathic arthritis in the nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. Journal of Rheumatology 2003 30 10 2275 2282 2-s2.0-10744233775 (Pubitemid 37221864)
12. Huemer C., Huemer M., Dorner T., Falger J., Schacherl H., Bernecker M., Artacker G., Pilz I., Incidence of pediatric rheumatic diseases in a regional population in Austria. Journal of Rheumatology 2001 28 9 2116 2119 2-s2.0-0034863268 (Pubitemid 32803793)
13. Kaipiainen-Seppänen O., Savolainen A., Changes in the incidence of juvenile rheumatoid arthritis in Finland. Rheumatology 2001 40 8 928 932 2-s2.0-0034869031
14. Malleson P. N., Fung M. Y., Rosenberg A. M., The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association disease registry. Journal of Rheumatology 1996 23 11 1981 1987 2-s2.0-0029956425 (Pubitemid 26376128)
15. Pelkonen P. M., Jalanko H. J., Lantto R. K., Makela A. L., Pietikainen M. A., Savolainen H. A., Verronen P. M., Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland. Journal of Rheumatology 1994 21 11 2143 2146 2-s2.0-0028027575 (Pubitemid 24352367)
16. Müller K., Herner E. B., Stagg A., Bendtzen K., Woo P., Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. British Journal of Rheumatology 1998 37 5 562 569 2-s2.0-0346340916
17. Murray K. J., Grom A. A., Thompson S. D., Lieuwen D., Passo M. H., Glass D. N., Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. Journal of Rheumatology 1998 25 7 1388 1398 2-s2.0-0031809101 (Pubitemid 28312360)
18. Date Y., Seki N., Kamizono S., Higuchi T., Hirata T., Miyata K., Ohkuni M., Tatsuzawa O., Yokota S., Joo K., Ueda K., Sasazuki T., Kimura A., Itoh K., Kato H., Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNF α gene and HLA genes. Arthritis and Rheumatism 1999 42 12 2577 2582 2-s2.0-0033512202 10.1002/1529-0131(199912)42:122577::AID-ANR10>3.0.CO;2-O (Pubitemid 30327174)
19. De Benedetti F., Pignatti P., Bernasconi S., Gerloni V., Matsushima K., Caporali R., Montecucco C. M., Sozzani S., Fantini F., Martini A., Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. Journal of Rheumatology 1999 26 2 425 431 2-s2.0-0032925392 (Pubitemid 29066750)
20. De Benedetti F., Vivarelli M., Pignatti P., Oliveri M., Massa M., Pistorio A., Martini A., Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. Journal of Rheumatology 2000 27 9 2246 2250 2-s2.0-0033821914
21. Bloom B. J., Miller L. C., Tucker L. B., Schaller J. G., Blier P. R., Soluble adhesion molecules in juvenile rheumatoid arthritis. Journal of Rheumatology 1999 26 9 2044 2048 2-s2.0-0033454107 (Pubitemid 30007078)
22. Dinarello C. A., Biologic basis for interleukin-1 in disease. Blood 1996 87 6 2095 2147 2-s2.0-0029979369 (Pubitemid 26086851)
23. Pascual V., Allantaz F., Patel P., Palucka A. K., Chaussabel D., Banchereau J., How the study of children with rheumatic diseases identified interferon- α and interleukin-1 as novel therapeutic targets. Immunological Reviews 2008 223 1 39 59 2-s2.0-47249152715 10.1111/j.1600-065X. 2008.00643.x (Pubitemid 351986188)
24. Rooney M., David J., Symons J., Di Giovine F., Varsani H., Woo P., Paediatric rheumatology: original article inflammatory cytokine responses in juvenile chronic arthritis. British Journal of Rheumatology 1995 34 5 454 460 2-s2.0-0029294089
25. De Benedetti F., Targeting interleukin-6 in pediatric rheumatic diseases. Current Opinion in Rheumatology 2009 21 5 533 537 2-s2.0-69549124775 10.1097/BOR.0b013e32832f1445
26. Raj D. S. C., Role of interleukin-6 in the anemia of chronic disease. Seminars in Arthritis and Rheumatism 2009 38 5 382 388 2-s2.0-62849089145 10.1016/j.semarthrit.2008.01.006
27. Wong P. K. K., Quinn J. M. W., Sims N. A., Van Nieuwenhuijze A., Campbell I. K., Wicks I. P., Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis and Rheumatism 2006 54 1 158 168 2-s2.0-31044449633 10.1002/art.21537 (Pubitemid 43122198)
28. De Jager W., Vastert S. J., Beekman J. M., Wulffraat N. M., Kuis W., Coffer P. J., Prakken B. J., Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism 2009 60 9 2782 2793 2-s2.0-69449093422 10.1002/art.24750
29. Frosch M., Vogl T., Seeliger S., Wulffraat N., Kuis W., Viemann D., Foell D., Sorg C., Sunderkötter C., Roth J., Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis and Rheumatism 2003 48 9 2622 2626 2-s2.0-0141788322 10.1002/art.11177 (Pubitemid 37129439)
30. Frosch M., Ahlmann M., Vogl T., Wittkowski H., Wulffraat N., Foell D., Roth J., The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism 2009 60 3 883 891 2-s2.0-61749104104 10.1002/art.24349
31. Meazza C., Travaglino P., Pignatti P., Magni-Manzoni S., Ravelli A., Martini A., De Benedetti F., Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis and Rheumatism 2002 46 1 232 237 2-s2.0-0036163743 10.1002/1529-0131(200201)46:1232::AID-ART10059>3.0.CO;2-B (Pubitemid 34121669)
32. Cinek O., Vavincová P., Striz I., Devínek P., Sedláková P., Vavinec J., Slavčev A., Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. Journal of Rheumatology 2004 31 6 1206 1210 2-s2.0-2642569199 (Pubitemid 38715900)
33. Möller J. C., Paul D., Ganser G., Range U., Gahr M., Kelsch R., Rosen-Wolff A., Hedrich C. M., christian.hedrich@uniklinikum-dresden.de IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clinical and Experimental Rheumatology 2010 28 6 912 918
34. Vastert S. J., Kuis W., Grom A. A., Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Best Practice and Research 2009 23 5 655 664 2-s2.0-71749093502 10.1016/j.berh.2009.08.003
35. Ozen S., Hoffman H. M., Frenkel J., Kastner D., Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6-10 November 2005. Annals of the Rheumatic Diseases 2006 65 7 961 964 2-s2.0-33745686186 10.1136/ard.2006.052688
36. Aksentijevich I., Centola M., Deng Z., Sood R., Balow J. E., Wood G., Zaks N., Mansfield E., Chen X., Eisenberg S., Vedula A., Shafran N., Raben N., Pras E., Pras M., Kastner D. L., Blake T., Baxevanis A. D., Robbins C., Krizman D., Collins F. S., Liu P. P., Chen X., Shohat M., Hamon M., Kahan T., Cercek A., Rotter J. I., Fischel-Ghodsian N., Richards N., Shelton D. A., Gumucio D., Yokoyama Y., Mangelsdorf M., Orsborn A., Richards R. I., Ricke D. O., Buckingham J. M., Moyzis R. K., Deaven L. L., Doggett N. A., Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997 90 4 797 807 2-s2.0-0030745449 10.1016/S0092-8674(00)80539-5 (Pubitemid 27357970)
37. Bernot A., Clepet C., Dasilva C., Devaud C., Petit J. L., Caloustian C., Cruaud C., Samson D., Pulcini F., Weissenbach J., Heilig R., Notanicola C., Domingo C., Rozenbaum M., Benchetrit E., Topaloglu R., Dewalle M., Dross C., Hadjari P., Dupant M., Demaille J., Touitou I., Smaoui N., Nedelec B., Méry J. P., Chaabouni H., Delpech M., Grateau G., A candidate gene for familial Mediterranean fever. Nature Genetics 1997 17 1 25 31 2-s2.0-16944365196 10.1038/ng0997-25 (Pubitemid 27377528)
38. Cattan D., MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Current Drug Targets 2005 4 1 105 112 2-s2.0-17844403541 10.2174/1568010053622948 (Pubitemid 40584860)
39. Ayaz N. A., Özen S., Bilginer Y., Ergüven M., Taşkiran E., Yilmaz E., Beşbaş N., Topalolu R., Bakkalolu A., MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology 2009 48 1 23 25 2-s2.0-57349147019 10.1093/rheumatology/ken409
40. Touitou I., Lesage S., McDermott M., Cuisset L., Hoffman H., Dode C., Shoham N., Aganna E., Hugot J. P., Wise C., Waterham H., Pugnere D., Demaille J., De Menthiere C. S., Infevers: an evolving mutation database for auto-inflammatory syndromes. Human Mutation 2004 24 3 194 198 2-s2.0-4143125654 10.1002/humu.20080 (Pubitemid 39095595)
41. Ben-Chetrit E., Touitou I., Familial mediterranean fever in the world. Arthritis Care and Research 2009 61 10 1447 1453 2-s2.0-70349774428 10.1002/art.24458
42. Woo P., Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nature Clinical Practice Rheumatology 2006 2 1 28 34 2-s2.0-31544465967 10.1038/ncprheum0084 (Pubitemid 43153646)
43. Chae J. J., Wood G., Masters S. L., Richard K., Park G., Smith B. J., Kastner D. L., The B30.2 domain of pyrin, the familial mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1 β production. Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 9982 9987 2-s2.0-33745631232 10.1073/pnas.0602081103 (Pubitemid 43993609)
44. Yalçinkaya F., Ozçakar Z. B., Kasapçoupur O., Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. The Journal of Pediatrics 2007 151 6 675 678 2-s2.0-36148992959 10.1016/j.jpeds. 2007.04.062 (Pubitemid 350116122)
45. Gershoni-Baruch R., Broza Y., Brik R., Prevalence and significance of mutations in the familial Mediterranean fever gene in henoch-schönlein purpura. The Journal of Pediatrics 2003 143 5 658 661 2-s2.0-0344011080 10.1067/S0022-3476(03)00502-X (Pubitemid 37452797)
46. Atagunduz P., Ergun T., Direskeneli H., MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clinical and Experimental Rheumatology 2003 21 4 S35 S37 2-s2.0-0141669189 (Pubitemid 37193095)
47. Imirzalioglu N., Dursun A., Tastan B., Soysal Y., Yakicier M. C., MEFV gene is a probable susceptibility gene for Behçet's disease. Scandinavian Journal of Rheumatology 2005 34 1 56 58 2-s2.0-15944398723 10.1080/ 03009740510017931 (Pubitemid 40445060)
48. Rabinovich E., Shinar Y., Leiba M., Ehrenfeld M., Langevitz P., Livneh A., Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis. Scandinavian Journal of Rheumatology 2007 36 1 48 52 2-s2.0-34147145971 10.1080/03009740600759639 (Pubitemid 46572912)
49. Ayesh S., Abu-Rmaileh H., Nassar S., Al-Shareef W., Abu-Libdeh B., Muhanna A., Al-Kafri F., Molecular analysis of MEFV gene mutations among Palestinian patients with Behçet's disease. Scandinavian Journal of Rheumatology 2008 37 5 370 374 2-s2.0-52949148878 10.1080/03009740801998788
50. Lachmann H. J., Şengül B., Yavuzşen T. U., Booth D. R., Booth S. E., Bybee A., Gallimore J. R., Soytürk M., Akar S., Tunca M., Hawkins P. N., Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology 2006 45 6 746 750 2-s2.0-33744762729 10.1093/rheumatology/kei279 (Pubitemid 43985345)
51. Kalyoncu M., Acar B. C., Cakar N., Bakkaloglu A., Ozturk S., Dereli E., Tunca M., Kasapcopur O., Yalcinkaya F., Ozen S., Are carriers for MEFV mutation healthy? Clinical and Experimental Rheumatology 2006 24 5 S120 S122 2-s2.0-33750729262 (Pubitemid 44696893)
52. Grom A. A., Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Current Opinion in Rheumatology 2003 15 5 587 590 2-s2.0-0041828636 10.1097/00002281-200309000-00011 (Pubitemid 37041397)
53. Vastert S. J., van Wijk R., D'Urbano L. E., de Vooght K. M., de Jager W., Ravelli A., Magni-Manzoni S., Insalaco A., Cortis E., van Solinge W. W., Prakken B. J., Wulffraat N. M., de Benedetti F., Kuis W., Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology 2009 49 3 441 449 2-s2.0-77950531755 10.1093/rheumatology/kep418 kep418
54. Grom A. A., Mellins E. D., Macrophage activation syndrome: advances towards understanding pathogenesis. Current Opinion in Rheumatology 2010 22 5 561 566 2-s2.0-77955172764 10.1097/01.bor.0000381996.69261.71
55. Zhang K., Biroschak J., Glass D. N., Thompson S. D., Finkel T., Passo M. H., Binstadt B. A., Filipovich A., Grom A. A., Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis and Rheumatism 2008 58 9 2892 2896 2-s2.0-49749127387 10.1002/art.23734
56. Yanagimachi M., m-yanagi@mvi.biglobe.ne.jp Naruto T., Miyamae T., Hara T., Kikuchi M., Hara R., Imagawa T., Mori M., Sato H., Goto H., Yokota S., Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. Journal of Rheumatology 2011 38 4 769 774 10.3899/jrheum.100655
57. Donn R., Ellison S., Lamb R., Day T., Baildam E., Ramanan A. V., Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism 2008 58 3 869 874 2-s2.0-40549125931 10.1002/art.23270 (Pubitemid 351364886)
58. Modesto C., Woo P., García-Consuegra J., Merino R., García-Granero M., Arnal C., Prieur A. M., Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clinical and Experimental Rheumatology 2001 19 2 211 217 2-s2.0-0035042051 (Pubitemid 32372462)
59. Bloom B. J., Tucker L. B., Miller L. C., Schaller J. G., Fibrin d-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis. Journal of Rheumatology 1998 25 8 1620 1625 2-s2.0-0031880753 (Pubitemid 28364772)
60. Behrens E. M., Beukelman T., Paessler M., Cron R. Q., Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. Journal of Rheumatology 2007 34 5 1133 1138 2-s2.0-34248666067 (Pubitemid 46774861)
61. Davì S., Consolaro A., Guseinova D., Pistorio A., Ruperto N., Martini A., Cron R. Q., Ravelli A., angeloravelli@ospedale-gaslini.ge.it An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. Journal of Rheumatology 2011 38 4 764 768 10.3899/jrheum.100996
62. Calabro J. J., Marchesano J. M., Fever associated with juvenile rheumatoid arthritis. The New England Journal of Medicine 1967 276 1 11 18 2-s2.0-0014193062
63. McMinn F. J., Bywaters E. G., Differences between the fever of Still's disease and that of rheumatic fever. Annals of the Rheumatic Diseases 1959 18 4 293 297
64. Schaller J., Wedgwood R. J., Juvenile rheumatoid arthritis: a review. Pediatrics 1972 50 6 940 953 2-s2.0-0015456193
65. Calabro J. J., Holgerson W. B., Sonpal G. M., Khoury M. I., Juvenile rheumatoid arthritis: a general review and report of 100 patients observed for 15 years. Seminars in Arthritis and Rheumatism 1976 5 3 257 298 2-s2.0-0017290749 10.1016/0049-0172(76)90027-5
66. Schlesinger B., Rheumatoid arthritis in the young. BMJ Journals 1949 2 4620 197 201
67. Weiss P. F., Arabshahi B., Johnson A., Bilaniuk L. T., Zarnow D., Cahill A. M., Feudtner C., Cron R. Q., High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound. Arthritis and Rheumatism 2008 58 4 1189 1196 2-s2.0-42449102506 10.1002/art.23401 (Pubitemid 351564022)
68. Arabshahi B., Cron R. Q., Temporomandibular joint arthritis in juvenile idiopathic arthritis: the forgotten joint. Current Opinion in Rheumatology 2006 18 5 490 495 2-s2.0-33746910630 10.1097/01.bor.0000240360.24465.4c (Pubitemid 44200333)
69. Schaller J. G., Juvenile rheumatoid arthritis: series 1. Arthritis & Rheumatism 1977 20 2 165 170 2-s2.0-0017460576
70. Bloom B. J., Tucker L. B., Miller L. C., McCauley R. G. K., Schaller J. G., Bicipital synovial cysts in juvenile rheumatoid arthritis: clinical description and sonographic correlation. Journal of Rheumatology 1995 22 10 1953 1955 2-s2.0-0028787807
71. Costello P. B., Kennedy A. C., Green F. A., Shoulder joint rupture in juvenile rheumatoid arthritis producing bicipital masses and a hemorrhagic sign. Journal of Rheumatology 1980 7 4 563 566 2-s2.0-0019253815 (Pubitemid 11160527)
72. Dell'Era L., Vercellesi P., Forzenigo L. V., Carnelli V., Corona F., Synovial cyst in juvenile idiopathic arthritis. Clinical Rheumatology 2008 27 2 43 45 2-s2.0-56349108556 10.1007/s10067-008-0860-x
73. Shimizu M., Yokoyama T., Wada T., Yachie A., Bicipital synovial cyst in systemic-onset juvenile idiopathic arthritis. The Journal of Pediatrics 2010 157 1, article 168 2-s2.0-77953285070 10.1016/j.jpeds.2010.02.014
74. Ambrósio C., Abreu P., Alexandre M., Malcata A., Lymphoedema in systemic juvenile arthritis: a rare extraarticular feature. Acta Reumatologica Portuguesa 2008 33 4 457 459 2-s2.0-59649115877
75. Bywaters E. G., Isdale I. C., The rash of rheumatoid arthritis and Still's disease. The Quarterly journal of medicine 1956 25 99 377 387 2-s2.0-0000806321
76. Calabro J. J., Marchesano J. M., Rash associated with juvenilerheumatoid arthritis. The Journal of Pediatrics 1968 72 5 611 619 2-s2.0-0014288562
77. Schaller J., Wedgwood R. J., Pruritis associated with the rash of juvenile rheumatoid arthritis. Pediatrics 1970 45 2 296 298 2-s2.0-0014733183
78. Calabro J. J., Katz R. M., Marchesano J. M., Schaller J., Pruritus in juvenile rheumatoid arthritis. Pediatrics 1970 46 2 322 323 2-s2.0-0014835044
79. Kunz M., Roth J., Sorg C., Kolde G., Epidermal expression of the calcium binding surface antigen 27E10 in inflammatory skin diseases. Archives of Dermatological Research 1992 284 7 386 390 2-s2.0-0027096788 10.1007/BF00372067 (Pubitemid 23009894)
80. Kelly S. E., Jones D. B., Fleming S., Calgranulin expression in inflammatory dermatoses. Journal of Pathology 1989 159 1 17 21 2-s2.0-0024442773 (Pubitemid 19232102)
81. Frosch M., Metze D., Foell D., Vogl T., Sorg C., Sunderkötter C., Roth J., Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis. Experimental Dermatology 2005 14 4 259 265 2-s2.0-16844382496 10.1111/j.0906-6705.2005.00271.x (Pubitemid 40485453)
82. Fortna R. R., Gudjonsson J. E., Seidel G., Dicostanzo D., Jacobson M., Kopelman M., Patel R. M., Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease. Journal of Cutaneous Pathology 2010 37 9 932 937 2-s2.0-77954524966 10.1111/j.1600-0560.2010.01570.x
83. Muskardin T. W., Binstadt B. A., Malar rash in systemic juvenile idiopathic arthritis. Journal of Rheumatology 2010 37 10, article 2187 2-s2.0-77957865113 10.3899/jrheum.100266
84. Calabro J. J., Marchesano J. M., The early natural history of juvenile rheumatoid arthritis. A 10-year follow-up study of 100 cases. Medical Clinics of North America 1968 52 3 567 591 2-s2.0-0014284960
85. Schaller J., Beckwith B., Wedgwood R. J., Hepatic involvement in juvenile rheumatoid arthritis. The Journal of Pediatrics 1970 77 2 203 210 2-s2.0-0014830238
86. Goldenberg J., Ferraz M. B., Pessoa A. P., Fonseca A. S. M., Carvalho A. C., Hilario M. O., Atra E., Symptomatic cardiac involvement in juvenile rheumatoid arthritis. International Journal of Cardiology 1992 34 1 57 62 2-s2.0-0026599429 10.1016/0167-5273(92)90082-E
87. Lietman P. S., Bywaters E. G., Pericarditis in juvenile rheumatoid arthritis. Pediatrics 1963 32 855 860 2-s2.0-0005132814
88. Bywaters E. G., Death in juvenile chronic polyarthritis. Arthritis & Rheumatism 1977 20 supplement, article 256
89. Bernstein B., Death in juvenile rheumatoid arthritis. Arthritis & Rheumatism 1977 20 supplement 256 257
90. Baum J., Gutowska G., Death in juvenile rheumatoid arthritis. Arthritis & Rheumatism 1977 20 supplement 253 255
91. Bhettay E., Thomson A. J. G., Peritonitis in juvenile chronic arthritis. A report of 2 cases. South African Medical Journal 1985 68 8 605 606 2-s2.0-0022379920 (Pubitemid 16204735)
92. Calabro J. J., Other extraarticular manifestations of juvenile rheumatoid arthritis. Arthritis & Rheumatism 1977 20 2 237 240 2-s2.0-0017460580
93. Ishihara M., Nakamura S., Okada K., Yokota S., Ohno S., A case of juvenile rheumatoid arthritis with panuveitis. Journal of Japanese Ophthalmological Society 1992 96 1 109 113
94. Moore A. T., Morin J. D., Bilateral acquired inflammatory Brown's syndrome. Journal of Pediatric Ophthalmology and Strabismus 1985 22 1 26 30 2-s2.0-0022001779 (Pubitemid 15164861)
95. Wang F. M., Wertenbaker C., Behrens M. M., Jacobs J. C., Acquired Brown's syndrome in children with juvenile rheumatoid arthritis. Ophthalmology 1984 91 1 23 26 2-s2.0-0021327870 (Pubitemid 14184713)
96. Avčin T., Silverman E. D., Forte V., Schneider R., Nasal septal perforation: a novel clinical manifestation of systemic juvenile idiopathic arthritis/adult onset Still's disease. Journal of Rheumatology 2005 32 12 2429 2431 2-s2.0-28844470222 (Pubitemid 41780659)
97. Wagener J. S., Taussig L. M., DeBenedetti C., Pulmonary function in juvenile rheumatoid arthritis. The Journal of Pediatrics 1981 99 1 108 110 2-s2.0-0019455537 (Pubitemid 11046433)
98. Van Der Net J., Kuis W., Prakken A. B. J., Lukkassen I., Sinnema G., Hutter A. P., Brackel H. J. L., De Wilde E. J., Helders P. J. M., Correlates of disablement in systemic onset juvenile chronic arthritis: a cross sectional study. Scandinavian Journal of Rheumatology 1997 26 3 188 196 2-s2.0-0030854463 (Pubitemid 27286489)
99. Athreya B. H., Doughty R. A., Bookspan M., Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review. Clinics in Chest Medicine 1980 1 3 361 374 (Pubitemid 12251718)
100. Padeh S., Laxer R. M., Silver M. M., Silverman E. D., Primary pulmonary hypertension in a patient with systemic-onset juvenile arthritis. Arthritis and Rheumatism 1991 34 12 1575 1579 2-s2.0-0026316778
101. Schultz R., Mattila J., Gappa M., Verronen P., Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemic juvenile arthritis (CJA). Pediatric Pulmonology 2001 32 5 397 402 2-s2.0-0034753023 10.1002/ppul.1149 (Pubitemid 33015657)
102. Binstadt B. A., Levine J. C., Nigrovic P. A., Gauvreau K., Dedeoglu F., Fuhlbrigge R. C., Weindling S. N., Newburger J. W., Sundel R. P., Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics 2005 116 1 e89 e93 2-s2.0-33644621446 10.1542/peds.2004-2190
103. Maeno N., Takei S., Nomura Y., Imanaka H., Hokonohara M., Miyata K., Yamamura M., Kawashima M., Makino H., Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al [2] (multiple letters). Arthritis & Rheumatism 2002 46 9 2539 2542 2-s2.0-0036746084 10.1002/art.10389
104. David J., Amyloidosis in juvenile chronic arthritis. Clinical and Experimental Rheumatology 1991 9 1 73 78 2-s2.0-0026101737
105. Grateau G., gilles.grateau@htd.ap-hop-paris.fr Musculoskeletal disorders in secondary amyloidosis and hereditary fevers. Best Practice and Research 2003 17 6 929 944 10.1016/j.berh.2003.09.002 (Pubitemid 38324646)
106. Schnitzer T. J., Ansell B. M., Amyloidosis in juvenile chronic polyarthritis. Arthritis & Rheumatism 1977 20 2, supplement 245 252
107. Ozdogan H., Kasapcopur O., Dede H., Arisoy N., Beceren T., Yurdakul S., Yazici H., Juvenile chronic arthritis in a Turkish population. Clinical and Experimental Rheumatology 1991 9 4 431 435 2-s2.0-0025733627
108. Woo P., Amyloidosis in pediatric rheumatic diseases. Journal of Rheumatology 1992 19 supplement 35 10 16
109. David J., Vouyiouka O., Ansell B. M., Hall A., Woo P., Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clinical and Experimental Rheumatology 1993 11 1 85 90 2-s2.0-0027529335 (Pubitemid 23050859)
110. Immonen K., Savolainen A., Kautiainen H., Hakala M., Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis. Journal of Rheumatology 2008 35 5 907 912 2-s2.0-44349141890 (Pubitemid 351747136)
111. Hadchouel M., Prieur A. M., Griscelli C., Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. The Journal of Pediatrics 1985 106 4 561 566 2-s2.0-0021804014 (Pubitemid 15080542)
112. Stephan J. L., Zeller J., Hubert P., Herbelin C., Dayer J. M., Prieur A. M., Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clinical and Experimental Rheumatology 1993 11 4 451 456 2-s2.0-0027364029 (Pubitemid 23287170)
113. Prieur A. M., Stephan J. L., Macrophage activation syndrome in children with joint diseases. Revue du Rhumatisme 1994 61 6 385 388 2-s2.0-0028356815 (Pubitemid 24220712)
114. Grom A. A., Passo M., Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. The Journal of Pediatrics 1996 129 5 630 632 2-s2.0-0030370451 10.1016/S0022-3476(96)70140-3 (Pubitemid 27498267)
115. Athreya B. H., Is macrophage activation syndrome a new entity? Clinical and Experimental Rheumatology 2002 20 2 121 123 2-s2.0-0035990141 (Pubitemid 34413689)
116. Ravelli A., Macrophage activation syndrome. Current Opinion in Rheumatology 2002 14 5 548 552 10.1097/00002281-200209000-00012 (Pubitemid 34953793)
117. Ramanan A. V., Schneider R., Macrophage activation syndromewhat's in a name! Journal of Rheumatology 2003 30 12 2513 2516 2-s2.0-0346218149
118. Sawhney S., Woo P., Murray K. J., Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Archives of Disease in Childhood 2001 85 5 421 426 2-s2.0-0035511981 10.1136/adc.85.5.421 (Pubitemid 33702300)
119. Stéphan J. L., Koné-Paut I., Galambrun C., Mouy R., Bader-Meunier B., Prieur A. M., Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology 2001 40 11 1285 1292 2-s2.0-0035184142
120. Lehman T. J. A., Schechter S. J., Sundel R. P., Oliveira S. K., Huttenlocher A., Onel K. B., Thalidomide for severe systemic onset juvenile rheumatoid arthritis: a multicenter study. The Journal of Pediatrics 2004 145 6 856 857 2-s2.0-9744227982 10.1016/j.jpeds.2004.08.020 (Pubitemid 39586632)
121. Wallace C. A., Sherry D. D., Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. Arthritis and Rheumatism 1997 40 10 1852 1855 2-s2.0-0030833403 10.1002/art.1780401019 (Pubitemid 27452537)
122. Shaikov A. V., Maximov A. A., Speransky A. I., Lovell D. J., Giannini E. H., Solovyev S. K., Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritispreliminary results of a longterm study. Journal of Rheumatology 1992 19 4 612 616
123. Wulffraat N. M., van Rooijen E. M., Tewarie R., Brinkman D., Prakken B., Kuis W., Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis. Autoimmunity 2008 41 8 632 638 2-s2.0-55149100214 10.1080/08916930802200224
124. Laxer R. M., Schneider R., Isenberg D. A., Systemic-onset juvenile chronic arthritis. Oxford Textbook of Rheumatology 2004 Oxford, UK Oxford University Press 798 810
125. Halle F., Prieur A. M., Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype. Clinical and Experimental Rheumatology 1991 9 3 297 302 2-s2.0-0025804754
126. Speckmaier M., Findeisen J., Woo P., Hall A., Sills J. A., Pric e T., Hollingworth P., Craft A., Ansell B. M., Low-dose methotrexate in systemic onset juvenile chronic arthritis. Clinical and Experimental Rheumatology 1989 7 6 647 650 2-s2.0-0024951695 (Pubitemid 20100992)
127. Kimball A. B., Summers R. M., Turner M., Dugan E. M., Hicks J., Miller F. W., Rider L. G., Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis & Rheumatism 2000 43 8 1849 1857 (Pubitemid 30640941)
128. Lovell D. J., Reiff A., Ilowite N. T., Wallace C. A., Chon Y., Lin S. L., Baumgartner S. W., Giannini E. H., Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis & Rheumatism 2008 58 5 1496 1504 2-s2.0-43949143169 10.1002/art.23427 (Pubitemid 351705939)
129. Quartier P., Taupin P., Bourdeaut F., Lemelle I., Pillet P., Bost M., Sibilia J., Koné-Paut I., Gandon-Laloum S., LeBideau M., Bader-Meunier B., Mouy R., Debré M., Landais P., Prieur A. M., Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis & Rheumatism 2003 48 4 1093 1101 2-s2.0-0037388345 10.1002/art.10885 (Pubitemid 36418252)
130. Horneff G., Schmeling H., Biedermann T., Foeldvari I., Ganser G., Girschick H. J., Hospach T., Huppertz H. I., Keilzer R., Küster R. M., Michels H., Moebius D., Rogalski B., Thon A., The German etanercept registry for treatment of juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2004 63 12 1638 1644 2-s2.0-9644255827 10.1136/ard.2003.014886 (Pubitemid 39573695)
131. Kimura Y., Pinho P., Walco G., Higgins G., Hummell D., Szer I., Henrickson M., Watcher S., Reiff A., Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. Journal of Rheumatology 2005 32 5 935 942 2-s2.0-18744366356 (Pubitemid 40676507)
132. Russo R. A. G., Katsicas M. M., Clinical remission in patients with
133. Pascual V., Allantaz F., Arce E., Punaro M., Banchereau J., Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. Journal of Experimental Medicine 2005 201 9 1479 1486 2-s2.0-18644385243 10.1084/jem.20050473 (Pubitemid 40664091)
134. Irigoyen P., Olson J., Hom C., Ilowite N.T., Treatment of systemic onset juvenile rheumatoid arthritis with anakinra. Arthritis & Rheumatism 2004 50 supplement, article S438
135. Hashkes P. J., Laxer R. M., Medical treatment of juvenile idiopathic arthritis. JAMA 2005 294 13 1671 1684 2-s2.0-26044469891 10.1001/jama.294.13. 1671 (Pubitemid 41407360)
136. Brewer E. J., Giannini E. H., Baum J., Aspirin and fenoprofen (Nalfon®) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study. Journal of Rheumatology 1982 9 1 123 128 2-s2.0-0020326646 (Pubitemid 12091050)
137. Haapasaari J., Wuolijoki E., Ylijoki H., Treatment of juvenile rheumatoid arthritis with diclofenac sodium. Scandinavian Journal of Rheumatology 1983 12 4 325 330 (Pubitemid 14211818)
138. Kvien T. K., Hoyeraal H. M., Sandstad B., Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficiency in a single-centre 24-week double-blind parallel study. Scandinavian Journal of Rheumatology 1984 13 4 342 350 (Pubitemid 15188864)
139. Giannini E. H., Brewer E. J., Miller M. L., Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric rheumatology collaborative study group. The Journal of Pediatrics 1990 117 4 645 652 (Pubitemid 20332114)
140. 2011 August .
141. Dowd J. E., Cimaz R., Fink C. W., Nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children. Arthritis & Rheumatism 1995 38 9 1225 1231 2-s2.0-0029094156 10.1002/art.1780380908
142. Mulberg A. E., Linz C., Bern E., Tucker L., Verhave M., Grand R. J., Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. The Journal of Pediatrics 1993 122 4 647 649 2-s2.0-0027533466 (Pubitemid 23093600)
143. Lang B. A., Finlayson L. A., Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis. The Journal of Pediatrics 1994 124 4 639 642 2-s2.0-0028330417 (Pubitemid 24128166)
144. Mehta S., Lang B., Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis. Arthritis & Rheumatism 1999 42 10 2252 2254 2-s2.0-0033509411 10.1002/1529-0131(199910)42:102252::AID-ANR33>3.0. CO;2-2 (Pubitemid 30263616)
145. De Silva B., Banney L., Uttley W., Luqmani R., Schofield O., Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. Pediatric Dermatology 2000 17 6 480 483 2-s2.0-0034524603 10.1046/j.1525-1470.2000.01827.x (Pubitemid 32039314)
146. Kimura Y., Fieldston E., Devries-Vandervlugt B., Li S., Imundo L., High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. Journal of Rheumatology 2000 27 8 2018 2024 2-s2.0-0033844441 (Pubitemid 30670496)
147. Adebajo A. O., Hall M. A., The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. British Journal of Rheumatology 1998 37 11 1240 1242 2-s2.0-0031728975
148. Satel S. L., Mental status changes in children receiving glucocorticoids. Review of the literature. Clinical Pediatrics 1990 29 7 382 388 2-s2.0-0025452669 (Pubitemid 20254815)
149. Havelka S., Vavrincova P., Stepan J., Metabolic bone status in young women with juvenile chronic arthritis. Journal of Rheumatology 1993 20 supplement 37 14 16 (Pubitemid 23128476)
150. Reeve J., Loftus J., Hesp R., Ansell B. M., Wright D. J., Woo P. M. M., Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids. Journal of Rheumatology 1993 20 7 1189 1195 2-s2.0-0027267782 (Pubitemid 23278174)
151. Spahn J. D., Kamada A. K., Special considerations in the use of glucocorticoids in children. Pediatrics in Review 1995 16 7 266 272 2-s2.0-0029337244
152. Kumararatne D. S., Gagnon R. F., Smart Y., Selective loss of large lymphocytes from the marginal zone of the white pulp in rat spleen following a single dose of cyclophosphamide. A study using quantitative histological methods. Immunology 1980 40 1 123 131 2-s2.0-0018899214 (Pubitemid 10116315)
153. Youssef P. P., Triantafillou S., Parker A., Coleman M., Roberts-Thomson P. J., Ahern M. J., Smith M. D., Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis: reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis & Rheumatism 1996 39 12 1970 1979
154. Youssef P. P., Roberts-Thomson P., Ahern M., Smith M., Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype. Journal of Rheumatology 1995 22 11 2065 2071 2-s2.0-0028835139
155. Lehman T. J., Clinical trials for the treatment of systemic onset juvenile rheumatoid arthritis-juvenile idiopathic arthritis. Current Rheumatology Reports 2000 2 4 313 315 2-s2.0-0034252055
156. Chen C. Y., Chen L. C., Yeh K. W., Ou L. S., Yang M. H., Huang J. L., Sequential changes to clinical parameters and adhesion molecules following intravenous pulse cyclophosphamide and methylprednisolone treatment of refractory juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 2004 22 2 259 264 2-s2.0-1842474336
157. Klein A., Horneff G., Treatment strategies for juvenile idiopathic arthritis. Expert Opinion on Pharmacotherapy 2009 10 18 3049 3060 2-s2.0-71449083526 10.1517/14656560903386300
158. Lequerré T., Quartier P., Rosellini D., Alaoui F., De Bandt M., Mejjad O., Kone-Paut I., Michel M., Demis E., Khellaf M., Limai N., Job-Deslandre C., Fautrel B., Le Loët X., Sibilia J., Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Annals of the Rheumatic Diseases 2008 67 3 302 308 2-s2.0-39549109506 10.1136/ard.2007.076034 (Pubitemid 351281262)
159. Gattorno M., Piccini A., Lasigliè D., Tassi S., Brisca G., Carta S., Delfino L., Ferlito F., Pelagatti M. A., Caroli F., Buoncompagni A., Viola S., Loy A., Sironi M., Vecchi A., Ravelli A., Martini A., Rubartelli A., The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis & Rheumatism 2008 58 5 1505 1515 2-s2.0-43949116263 10.1002/art.23437 (Pubitemid 351705940)
160. Ohlsson V., Baildam E., Foster H., Jandial S., Pain C., Strike H., Ramanan A. V., Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology 2008 47 4 555 556 2-s2.0-43049158200 10.1093/rheumatology/ken030
161. Zeft A., Hollister R., Lafleur B., Sampath P., Soep J., McNally B., Kunkel G., Schlesinger M., Bohnsack J., Anakinra for systemic juvenile arthritis: the rocky mountain experience. Journal of Clinical Rheumatology 2009 15 4 161 164 2-s2.0-67650866194 10.1097/RHU.0b013e3181a4f459
162. Nigrovic P. A., pnigrovic@partners.org Mannion M., Prince F. H.M., Zeft A., Rabinovich C. E., Van Rossum M. A.J., Cortis E., Pardeo M., Miettunen P. M., Janow G., Birmingham J., Eggebeen A., Janssen E., Shulman A. I., Son M. B., Hong S., Jones K., Ilowite N. T., Cron R. Q., Higgins G. C., Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis & Rheumatism 2011 63 2 545 555 10.1002/art.30128
163. Lovell D. J., Giannini E. H., Kimura Y., Preliminary evidence for sustained bioactivity of IL-1 trap (rilonacept), a long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis (sJIA). Arthritis & Rheumatism 2007 56 supplement S514 S515
164. Lachmann H. J., Kone-Paut I., Kuemmerle-Deschner J. B., Leslie K. S., Hachulla E., Quartier P., Gitton X., Widmer A., Patel N., Hawkins P. N., Use of canakinumab in the cryopyrin-associated periodic syndrome. The New England Journal of Medicine 2009 360 23 2416 2425 2-s2.0-66649102432 10.1056/NEJMoa0810787
165. Sato K., Tsuchiya M., Saldanha J., Koishihara Y., Ohsugi Y., Kishimoto T., Bendig M. M., Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Research 1993 53 4 851 856 2-s2.0-0027502201 (Pubitemid 23077873)
166. Yokota S., Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis. Current Opinion in Rheumatology 2003 15 5 581 586 2-s2.0-0041328139 10.1097/00002281-200309000-00010 (Pubitemid 37041396)
167. Yokota S., Miyamae T., Imagawa T., Iwata N., Katakura S., Mori M., Woo P., Nishimoto N., Yoshizaki K., Kishimoto T., Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis & Rheumatism 2005 52 3 818 825 2-s2.0-20144362101 10.1002/art.20944 (Pubitemid 40365104)
168. Ruperto N., Lovell D. J., Quartier P., Paz E., Rubio-Pérez N., Silva C. A., Abud-Mendoza C., Burgos-Vargas R., Gerloni V., Melo-Gomes J. A., Saad-Magalhães C., Sztajnbok F., Goldenstein-Schainberg C., Scheinberg M., Penades I. C., Fischbach M., Orozco J., Hashkes P. J., Hom C., Jung L., Lepore L., Oliveira S., Wallace C. A., Sigal L. H., Block A. J., Covucci A., Martini A., Giannini E. H., Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. The Lancet 2008 372 9636 383 391 2-s2.0-48349093002 10.1016/S0140-6736(08)60998-8
169. Lovell D. J., Giannini E. H., Reiff A., Jones O. Y., Schneider R., Olson J. C., Stein L. D., Gedalia A., Ilowite N. T., Wallace C. A., Lange M., Finck B. K., Burge D. J., Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis & Rheumatism 2003 48 1 218 226 2-s2.0-0037231476 10.1002/art.10710 (Pubitemid 36091666)
170. Giannini E. H., Ruperto N., Ravelli A., Lovell D. J., Felson D. T., Martini A., Preliminary definition of improvement in juvenile arthritis. Arthritis & Rheumatism 1997 40 7 1202 1209 2-s2.0-0030960980 (Pubitemid 27430130)
171. Woo P., Wilkinson N., Prieur A. M., Southwood T., Leone V., Livermore P., Wythe H., Thomson D., Kishimoto T., Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research & Therapy 2005 7 6 R1281 1288 2-s2.0-31544451391
172. Yokota S., Imagawa T., Mori M., Miyamae T., Aihara Y., Takei S., Iwata N., Umebayashi H., Murata T., Miyoshi M., Tomiita M., Nishimoto N., Kishimoto T., Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. The Lancet 2008 371 9617 998 1006 2-s2.0-40749152243 10.1016/S0140-6736(08)60454-7 (Pubitemid 351389534)
173. De Benedetti F., Brunner H., Ruperto N., Efficacy and safety of tocilizumab in patients with systemic juvenile idiopathic arthritis (sJIA): 12-week data from the phase 3 TENDER trial. Annals of the Rheumatic Diseases 2010 69 supplement, article 146
174. 2011 October.
175. Moreland L. W., Alten R., Van Den Bosch F., Appelboom T., Leon M., Emery P., Cohen S., Luggen M., Shergy W., Nuamah I., Becker J. C., Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis & Rheumatism 2002 46 6 1470 1479 2-s2.0-0036275436 10.1002/art.10294 (Pubitemid 34620192)
176. Ruperto N., Lovell D. J., Quartier P., Paz E., Rubio-Pérez N., Silva C. A., Abud-Mendoza C., Burgos-Vargas R., Gerloni V., Melo-Gomes J. A., Saad-Magalhães C., Chavez-Corrales J., Huemer C., Kivitz A., Blanco F. J., Foeldvari I., Hofer M., Horneff G., Huppertz H. I., Job-Deslandre C., Loy A., Minden K., Punaro M., Nunez A. F., Sigal L. H., Block A. J., Nys M., Martini A., Giannini E. H., Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis & Rheumatism 2010 62 6 1792 1802 2-s2.0-77952898132 10.1002/art.27431
177. Ruperto N., Lovell D. J., Li T., Sztajnbok F., Goldenstein-Schainberg C., Scheinberg M., Penades I. C., Fischbach M., Alcala J. O., Hashkes P. J., Hom C., Jung L., Lepore L., Oliveira S., Wallace C., Alessio M., Quartier P., Cortis E., Eberhard A., Simonini G., Lemelle I., Chalom E. C., Sigal L. H., Block A., Covucci A., Nys M., Martini A., Giannini E. H., Paediatric Rheumatology International Trials Organisation (PRINTO), Pediatric Rheumatology Collaborative Study Group (PRCSG), Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. Arthritis Care & Research 2010 62 11 1542 1551
178. Record J. L., Beukelman T., Cron R. Q., Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series. The Journal of Rheumatology 2011 38 1 180 181
179. Lovell D. J., Reiff A., Jones O. Y., Schneider R., Nocton J., Stein L. D., Gedalia A., Ilowite N. T., Wallace C. A., Whitmore J. B., White B., Giannini E. H., Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis & Rheumatism 2006 54 6 1987 1994 2-s2.0-33745042988 10.1002/art.21885 (Pubitemid 43877949)
180. Mohler K. M., Torrance D. S., Smith C. A., Goodwin R. G., Stremler K. E., Fung V. P., Madani H., Widmer M. B., Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. Journal of Immunology 1993 151 3 1548 1561 (Pubitemid 23219293)
181. Lovell D. J., Giannini E. H., Reiff A., Cawkwell G. D., Silverman E. D., Nocton J. J., Stein L. D., Gedalia A., Ilowite N. T., Wallace C. A., Whitmore J., Finck B. K., Etanercept in children with polyarticular juvenile rheumatoid arthritis. The New England Journal of Medicine 2000 342 11 763 769 10.1056/NEJM200003163421103 (Pubitemid 30151920)
182. Tynjälä P., pirjo.tynjala@hus.fi Vähäsalo P., Honkanen V., Lahdenne P., Drug survival of the first and second course of antitumour necrosis factor agents in juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2009 68 4 552 557 10.1136/ard.2007.087130
183. Katsicas M. M., Russo R. A. G., Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clinical and Experimental Rheumatology 2005 23 4 545 548 2-s2.0-26844516121 (Pubitemid 41447630)
184. Wouters C. H. P., Ceuppens J. L., Stevens E. A. M., Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 2002 20 2 239 248 2-s2.0-0035990194 (Pubitemid 34413708)
185. Kasher-Meron M., Uziel Y., Amital H., Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report. Rheumatology 2009 48 4 445 446 2-s2.0-63249113825 10.1093/rheumatology/ken492
186. Narváez J., Dáaz-Torné C., Juanola X., Geli C., Llobet J. M., Nolla J. M., Dáaz-López C., Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2009 68 4 607 608 2-s2.0-65249153520 10.1136/ard.2008.092106
187. Feito J. G., Pereda C. A., Rituximab therapy produced rapid and sustained clinical improvement in a patient with systemic onset juvenile idiopathic arthritis refractory to tnf alpha antagonists. Journal of Clinical Rheumatology 2009 15 7 363 365 2-s2.0-70350141204 10.1097/RHU.0b013e3181ba3c6f
188. Kahan B. D., Drug therapy: cyclosporine. The New England Journal of Medicine 1989 321 25 1725 1738 2-s2.0-0024976004 (Pubitemid 20020549)
189. Granelli-Piperno A., Inaba K., Steinman R. M., Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. Journal of Experimental Medicine 1984 160 6 1792 1802 2-s2.0-0021750822 (Pubitemid 15194004)
190. Thomson A. W., Webster L. M., The influence of cyclosporin A on cell-mediated immunity. Clinical and Experimental Immunology 1988 71 3 369 376 2-s2.0-0023841821 (Pubitemid 18079368)
191. Gerloni V., Cimaz R., Gattinara M., Arnoldi C., Pontikaki I., Fantini F., Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology 2001 40 8 907 913 2-s2.0-0034861568
192. Ruperto N., Ravelli A., Castell E., Gerloni V., Haefner R., Malattia C., Kanakoudi-Tsakalidou F., Nielsen S., Bohnsack J., Gibbas D., Rennebohm R., Voygioyka O., Balogh Z., Lepore L., Macejkova E., Wulffraat N., Oliveira S., Russo R., Buoncompagni A., Hilário M. O., Alpigiani M. G., Passo M., Lovell D. J., Giannini E. H., Merino R., Martini A., Murray K. J., Sztajnbok F., Jarosova K., Job-Deslandre C., Prieur A. M., Dressler F., Foeldvari I., Huppertz H. I., Kuester R. M., Schauer-Petrowskaja C., Pratsidou-Gertsi P., Orban I., Brik R., Mukamel M., Uziel Y., Barcellona R., Falcini F., Rudge S., Nordal E. B., Rygg M., Melo-Gomes J. A., Consuegra J. G., Gare B. A., Saurenmann T., Sauvain M. J., Ozen S., Baildam E., Bernstein B., Borzy M., Bowyer S., Cawkwell G., Finkel T., Graham B., Henrickson M., Ilowite N., Kimura Y., Lindsley C., Madson K., Szer I., Vehe R., Wallace C., Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study. Clinical and Experimental Rheumatology 2006 24 5 599 605 2-s2.0-33845475185 (Pubitemid 44911259)
193. Adams A., Lehman T. J. A., Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis. Current Opinion in Rheumatology 2005 17 5 612 616 2-s2.0-27344446522 10.1097/01.bor.0000169363.69066.d0 (Pubitemid 41527823)
194. Dredge K., k.dredge@sghms.ac.uk Marriott J. B., Dalgleish A. G., Immunological effects of thalidomide and its chemical and functional analogs. Critical Reviews in Immunology 2002 22 5-6 425 437 (Pubitemid 36548952)
195. Weber D., Thalidomide and its derivatives: new promise for multiple myeloma. Cancer Control 2003 10 5 375 383 2-s2.0-0142117347 (Pubitemid 37296064)
196. Corral L. G., Haslett P. A. J., Muller G. W., Chen R., Wong L. M., Ocampo C. J., Patterson R. T., Stirling D. I., Kaplan G., Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF- α Journal of Immunology 1999 163 1 380 386 2-s2.0-0033168605 (Pubitemid 29295864)
197. Lehman T. J. A., Striegel K. H., Onel K. B., Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis. The Journal of Pediatrics 2002 140 1 125 127 2-s2.0-0036161691 10.1067/mpd.2002.120835 (Pubitemid 34117479)
198. García-Carrasco M., Fuentes-Alexandro S., Escárcega R. O., Rojas-Rodriguez J., Escobar L. E., Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis. Joint Bone Spine 2007 74 5 500 503 2-s2.0-35348974044 10.1016/j.jbspin.2006.12.004 (Pubitemid 47595468)
199. Beukelman T., Patkar N. M., Saag K. G., Tolleson-Rinehart S., Cron R. Q., DeWitt E. M., Ilowite N. T., Kimura Y., Laxer R. M., Lovell D. J., Martini A., Rabinovich C. E., Ruperto N., 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care & Research 2011 63 4 465 482
200. Stoeber E., Prognosis in juvenile chronic arthritis. Follow-up of 433 chronic rheumatic children. European Journal of Pediatrics 1981 135 3 225 228 2-s2.0-0019414749 (Pubitemid 11137445)
201. Baum J., Alekseev L. S., Brewer Jr. E. J., Juvenile rheumatoid arthritis. A comparison of patients from the USSR and USA. Arthritis & Rheumatism 1980 23 9 977 984 (Pubitemid 10052090)
202. Ansell B. M., Wood P. H. N, Prognosis in juvenile chronic polyarthritis. Rheumatic Disease Clinical 1976 2 2 397 412
203. Schneider R., Lang B. A., Reilly B. J., Laxer R. M., Silverman E. D., Ibanez D., Bombardier C., Roifman C. M., Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. The Journal of Pediatrics 1992 120 2 200 205 2-s2.0-0026512048
204. Prieur A. M., Brémard-Oury C., Griscelli C., Mozziconacci P., Prognosis of the systemic forms of juvenile chronic arthritis. Apropos of 100 cases. Archives Françaises de Pédiatrie 1984 41 2 91 97 (Pubitemid 14127210)
205. Hafner R., Truckenbrodt H., Course and prognosis of systemic juvenile chronic arthritis: retrospective study of 187 patients. Klinische Padiatrie 1986 198 5 401 407 2-s2.0-0022512756 (Pubitemid 16017654)
206. Spiegel L. R., Schneider R., Lang B. A., Birdi N., Silverman E. D., Laxer R. M., Stephens D., Feldman B. M., Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis & Rheumatism 2000 43 11 2402 2409 2-s2.0-0033763981 10.1002/1529-0131(200011)43:112402::AID-ANR5>3.0.CO;2-C
207. Svantesson H., Akesson A., Eberhardt K., Elborgh R., Prognosis in juvenile rheumatoid arthritis with systemic onset. A follow-up study. Scandinavian Journal of Rheumatology 1983 12 2 139 144 (Pubitemid 13089859)
208. David J., Cooper C., Hickey L., Lloyd J., Dore C., McCullough C., Woo P., The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. British Journal of Rheumatology 1994 33 9 876 881 2-s2.0-0028064809 (Pubitemid 24283234)